Literature DB >> 32508430

Investigation of the in vitro cysticidal activity of miltefosine against Acanthamoeba spp.

Malin Chao1, Thaksaporn Thongseesuksai1, Thidarut Boonmars1,2, Porntip Laummaunwai1,2.   

Abstract

The present study evaluated the in vitro efficacy of miltefosine against cysts of Acanthamoeba spp. belonging to genotypes T3, T4 and T5. Each genotype was incubated with miltefosine at the concentration of 2.42, 4.84, 9.68, 19.36, 38.72 and 77.44 mM for different periods; 1, 3, 5, 7 d at 37 °C. The viability was assessed by staining with 0.4% trypan blue and culturing on NNA medium at 30 °C for 1 month. The results showed 100% eradication of cyst stage of all concentrations, but exhibited a different degree of activity against different genotypes. The MCC of 38.72 mM could kill genotype T4 and T5 after 1 d of incubation, whereas the killing of T3 needed MCC of 77.44 mM at the same incubation time. Miltefosine showed statistically highly significant difference (P < 0.001) in comparison to non-treated control. Although our finding needs to confirm in animal models, this information may be the guideline for optimizing therapy or considered to combine with the other drugs for effective treatment. © Indian Society for Parasitology 2020.

Entities:  

Keywords:  Acanthamoeba cyst; Genotypes; Miltefosine; Minimal cysticidal concentration

Year:  2020        PMID: 32508430      PMCID: PMC7244662          DOI: 10.1007/s12639-020-01204-w

Source DB:  PubMed          Journal:  J Parasit Dis        ISSN: 0971-7196


  14 in total

Review 1.  The increasing importance of Acanthamoeba infections.

Authors:  F Marciano-Cabral; R Puffenbarger; G A Cabral
Journal:  J Eukaryot Microbiol       Date:  2000 Jan-Feb       Impact factor: 3.346

2.  Acanthamoeba interactions with human brain microvascular endothelial cells.

Authors:  Selwa Alsam; Kwang Sik Kim; Monique Stins; Antonio Ortega Rivas; James Sissons; Naveed Ahmed Khan
Journal:  Microb Pathog       Date:  2003-12       Impact factor: 3.738

3.  Isolation and identification of Acanthamoeba species from natural water sources in the northeastern part of Thailand.

Authors:  Thani Thammaratana; Porntip Laummaunwai; Thidarut Boonmars
Journal:  Parasitol Res       Date:  2016-01-16       Impact factor: 2.289

4.  Variable responses of Acanthamoeba strains to three multipurpose lens cleaning solutions.

Authors:  Megan Shoff; Andrew Rogerson; Scott Schatz; David Seal
Journal:  Optom Vis Sci       Date:  2007-03       Impact factor: 1.973

Review 5.  Differentiation in Acanthamoeba castellanii.

Authors:  R A Weisman
Journal:  Annu Rev Microbiol       Date:  1976       Impact factor: 15.500

6.  In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri.

Authors:  Frederick L Schuster; B Joseph Guglielmo; Govinda S Visvesvara
Journal:  J Eukaryot Microbiol       Date:  2006 Mar-Apr       Impact factor: 3.346

Review 7.  Therapeutic agents and biocides for ocular infections by free-living amoebae of Acanthamoeba genus.

Authors:  Linda Christian Carrijo-Carvalho; Viviane Peracini Sant'ana; Annette Silva Foronda; Denise de Freitas; Fabio Ramos de Souza Carvalho
Journal:  Surv Ophthalmol       Date:  2016-11-09       Impact factor: 6.048

8.  Weak cytotoxic activity of miltefosine against clinical isolates of Acanthamoeba spp.

Authors:  M Mrva; M Garajová; M Lukáč; F Ondriska
Journal:  J Parasitol       Date:  2010-10-28       Impact factor: 1.276

9.  Molecular identification of t4 and t5 genotypes in isolates from acanthamoeba keratitis patients.

Authors:  D R Ledee; A Iovieno; D Miller; N Mandal; M Diaz; J Fell; M E Fini; E C Alfonso
Journal:  J Clin Microbiol       Date:  2009-03-25       Impact factor: 5.948

Review 10.  Biology and pathogenesis of Acanthamoeba.

Authors:  Ruqaiyyah Siddiqui; Naveed Ahmed Khan
Journal:  Parasit Vectors       Date:  2012-01-10       Impact factor: 3.876

View more
  2 in total

1.  Evaluation of in vitro activity of five antimicrobial agents on Acanthamoeba isolates and their toxicity on human corneal epithelium.

Authors:  Kirti Megha; Megha Sharma; Chayan Sharma; Amit Gupta; Rakesh Sehgal; Sumeeta Khurana
Journal:  Eye (Lond)       Date:  2021-09-21       Impact factor: 4.456

2.  Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs.

Authors:  Brian Shing; Mina Balen; James H McKerrow; Anjan Debnath
Journal:  Expert Rev Anti Infect Ther       Date:  2021-05-19       Impact factor: 5.091

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.